E, M., HM, A., TJ, A., AI, A., MM, S., A, A., . . . G, E. B. (2026). Role of insulin-like growth factor-1/2 and related signaling in parkinson's disease. Metabolic brain disease, 41(1), . https://doi.org/10.1007/s11011-026-01807-x
Chicago Style (17th ed.) CitationE, Manni, Al-Kuraishy HM, Al-Maiahy TJ, Al-Gareeb AI, Shokr MM, Alexiou A, Papadakis M, Hassan SM, and El-Saber Batiha G. "Role of Insulin-like Growth Factor-1/2 and Related Signaling in Parkinson's Disease." Metabolic Brain Disease 41, no. 1 (2026). https://doi.org/10.1007/s11011-026-01807-x.
MLA (9th ed.) CitationE, Manni, et al. "Role of Insulin-like Growth Factor-1/2 and Related Signaling in Parkinson's Disease." Metabolic Brain Disease, vol. 41, no. 1, 2026, https://doi.org/10.1007/s11011-026-01807-x.